Error loading player: No playable sources found
4290
Therapies Targeting the Microbiome to Treat GI Disorders
Date
May 20, 2024
SOCIETY: AGA This session will provide insight into the novel microbiome driven strategies to treat GI disorders. The talks in the session encompass the role of short-chain fatty acids and probiotics in disorders of GI motility and aging, the protective effects of Saccharomyces boulardii in colitis-associated colorectal cancer, and utility of fecal microbiota transplantation in inflammatory GI disorders.
Moderators
Mayo Clinic Minnesota
McMaster University
Related Products
AGA Diet Management in GI Cancers
The impact of diets on GI cancers has been well documented, however just recently we are understanding how diet impacts tumorigenesis…
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
Exploring the Dynamic Interactions Between Dietary Components, Microbiota, and Metabolic Health
SOCIETY: AGA The session will provide insights into the complex interplay between nutrition, microbial communities and metabolic health…
Gut Microbiota as the Orchestrator of Metabolic Disorders
SOCIETY: AGA The session will provide novel insights into the complex interactions between dietary choices, microbial dynamics, and metabolic health…
